ImmunityBio Inc.
IBRX | NASDAQ
$8.45
-$0.03 (-0.35%)
At close: Sep 21, 2026, 4:00 PM ET
$8.44
-$0.01 (-0.12%)
Pre-market:
Sep 22, 2026, 9:06 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 165.79M | 140.98M | 113.29M | 82.56M | 56.6M | 31.22M | 14.75M | 7.33M | 1.31M | 302K | 622K | 556K | 592K | 586K | 240K | 557K | 505K | 809K | 934K | 565K | 650K | 747K |
Cost of Revenue | 8.91M | 8.75M | 8.57M | 4.32M | 194K | 58K | n/a | n/a | n/a | n/a | 6.28M | 13.16M | 19.13M | 25.06M | 24.19M | 17.31M | 11.34M | 5.41M | n/a | 2.25M | 2.25M | 2.25M |
Gross Profit | 156.88M | 132.23M | 104.72M | 78.23M | 56.41M | 31.16M | 14.75M | 7.33M | 1.31M | 302K | -5.66M | -12.6M | -18.54M | -24.48M | -23.95M | -16.76M | -10.83M | -4.6M | 934K | -1.68M | -1.6M | -1.5M |
Operating Income | -251.8M | -261.39M | -256.03M | -260.74M | -285.37M | -313.42M | -344.18M | -360.17M | -360.05M | -345.87M | -362.25M | -361.08M | -371.75M | -366.23M | -350.62M | -345.67M | -333.7M | -339.99M | -330.28M | -281.89M | -268.93M | -233.94M |
Interest Income | 10.84M | 8.5M | 6.7M | 4.2M | 2.75M | 2.76M | 4.66M | 5.74M | 5.71M | 5.47M | 3.33M | 2M | 1.64M | 1.7M | 2.71M | 2.48M | 2.33M | 1.79M | 836K | 1.08M | 1.51M | 1.74M |
Pretax Income | -992.58M | -854.5M | -351.61M | -348.69M | -367.14M | -409.42M | -413.65M | -587.92M | -597.81M | -601.44M | -583.89M | -458.73M | -474.25M | -430.87M | -417.29M | -400.55M | -377.81M | -372.36M | -349.84M | -290.42M | -269.86M | -232.45M |
Net Income | -992.36M | -854.53M | -351.4M | -348.62M | -367.09M | -409.1M | -413.56M | -587.79M | -597.65M | -600.96M | -583.2M | -458.02M | -473.38M | -430.08M | -416.57M | -399.61M | -376.3M | -370M | -346.79M | -287.66M | -265.64M | -228.79M |
Selling & General & Admin | 165.75M | 157.46M | 145.66M | 149.55M | 152.64M | 159.55M | 168.78M | 160.16M | 156.06M | 138.83M | 123.84M | 115.3M | 101.31M | 84.38M | 96.78M | 100.12M | 111.91M | 129.27M | 135.26M | 115.75M | 105.72M | 91.62M |
Research & Development | 234M | 231.55M | 215.01M | 189.42M | 189.13M | 185.03M | 190.14M | 206.46M | 204.41M | 206.45M | 231.87M | 233.19M | 251.9M | 257.37M | 229.89M | 228.79M | 210.96M | 206.12M | 195.96M | 164.46M | 150.96M | 130.16M |
Other Expenses | 8.85M | 4.53M | n/a | n/a | n/a | n/a | n/a | 886K | 886K | 886K | 886K | n/a | n/a | n/a | n/a | -59K | -97K | -97K | -84K | -25K | 10.67M | 10.75M |
Operating Expenses | 408.68M | 393.62M | 360.75M | 338.98M | 341.77M | 344.58M | 358.93M | 367.5M | 361.36M | 346.17M | 356.59M | 348.48M | 353.21M | 341.75M | 326.67M | 328.92M | 322.87M | 335.39M | 331.21M | 280.21M | 267.34M | 232.44M |
Interest Expense | 83.26M | 112.12M | 112.53M | 100.24M | 112.9M | 123.04M | 131.66M | 148.88M | 143.65M | 136.87M | 128.94M | 125.37M | 107.12M | 84.58M | 63.52M | 39.44M | 26.29M | 20.17M | 14.85M | 13.2M | 11.81M | 10.35M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 417.59M | 402.37M | 369.32M | 343.3M | 341.97M | 344.64M | 358.93M | 367.5M | 361.36M | 346.17M | 362.87M | 361.64M | 372.34M | 366.81M | 350.86M | 346.23M | 334.21M | 340.8M | 331.21M | 282.46M | 269.58M | 234.69M |
Income Tax Expense | -179K | 90K | -135K | n/a | 35K | -234K | n/a | -40K | -40K | -40K | -40K | 34K | 34K | 34K | 34K | 1K | 1K | 3K | 9K | 7K | -1.69M | -1.65M |
Shares Outstanding (Basic) | 1.05B | 1.03B | 989.68M | 946.6M | 888.22M | 853.16M | 733.2M | 695.9M | 686.94M | 672.83M | 590.73M | 498.38M | 437.46M | 428.38M | 403.64M | 400.06M | 397.99M | 397.88M | 397.12M | 391.85M | 384.82M | 382.74M |
Shares Outstanding (Diluted) | 1.05B | 1.03B | 989.68M | 946.6M | 888.22M | 853.16M | 734.54M | 697.96M | 686.94M | 672.83M | 590.73M | 498.38M | 437.46M | 428.38M | 403.64M | 400.06M | 397.99M | 397.88M | 397.12M | 391.85M | 384.82M | 382.74M |
EPS (Basic) | -0.97 | -0.85 | -0.38 | -0.40 | -0.45 | -0.55 | -0.60 | -0.92 | -0.99 | -1.11 | -1.26 | -1.13 | -1.22 | -1.14 | -1.05 | -1.01 | -0.95 | -0.94 | -0.89 | -0.84 | -0.79 | -0.69 |
EPS (Diluted) | -0.97 | -0.85 | -0.38 | -0.41 | -0.46 | -0.56 | -0.61 | -0.92 | -0.99 | -1.11 | -1.26 | -1.13 | -1.22 | -1.14 | -1.05 | -1.01 | -0.95 | -0.94 | -0.89 | -0.84 | -0.79 | -0.69 |
EBITDA | -888.34M | -726.3M | -223.56M | -232.64M | -237.93M | -269.55M | -269.98M | -426.63M | -441.64M | -451.78M | -434.89M | -311.01M | -343.34M | -320.79M | -328.09M | -337.09M | -328.54M | -331.61M | -316.12M | -263.72M | -245.95M | -210.48M |
EBIT | -909.32M | -742.37M | -239.08M | -248.46M | -254.24M | -286.38M | -287.54M | -444.59M | -459.71M | -470.12M | -454.95M | -333.38M | -367.15M | -345.85M | -352.29M | -359.59M | -350.02M | -351.14M | -334.99M | -279.66M | -260.48M | -224.53M |
Depreciation & Amortization | 20.98M | 16.08M | 15.53M | 15.81M | 16.3M | 16.83M | 17.55M | 17.96M | 18.06M | 18.34M | 20.06M | 22.38M | 23.81M | 25.06M | 24.19M | 22.29M | 21.24M | 19.29M | 18.41M | 15.68M | 14.31M | 13.83M |
Add to Watchlist
Select watchlists to add or remove IBRX